advertisement
Clinical Ophthalmology 31
Showing records 1 to 25 | Display all abstracts in Clinical Ophthalmology25449 ReGAE 5: Can we improve the surgical journey for African-Caribbean patients undergoing glaucoma filtration surgery? Some preliminary findings
Cross V; Shah P; Glynn M; Chidrawar S
Clinical Ophthalmology 2009; 3: 1-12
25448 The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
Evans K; Law S K; Walt J; Buchholz P; Hansen J
Clinical Ophthalmology 2009; 3: 433-445
25467 Clinical evaluation of a rapid, pupil-based assessment of retinal damage associated with glaucoma
Wride N; Habib M; Morris K; Campbell S; Fraser S
Clinical Ophthalmology 2009; 3: 123-128
25462 Characteristics of respondents with glaucoma and dry eye in a national panel survey
Schmier J K; Covert D W
Clinical Ophthalmology 2009; 3: 645-650
25466 Central corneal thickness in subjects with glaucoma and in normal individuals (with or without pseudoexfoliation syndrome)
Kitsos G; Gartzios C; Asproudis I; Bagli E
Clinical Ophthalmology 2009; 3: 537-542
25451 New nonlinear multivariable model shows the relationship between central corneal thickness and HRTII topographic parameters in glaucoma patients
Kourkoutas D; Georgopoulos G; Maragos A; Apostolakis I; Tsekouras G; Karanasiou I S; Papaconstantinou D; Iliakis E; Moschos M
Clinical Ophthalmology 2009; 3: 313-323
25452 Investigation of the association between the GLC3A locus and normal tension glaucoma in Japanese patients by microsatellite analysis
Kamio M; Meguro A; Ota M; Nomura N; Kashiwagi K; Mabuchi F; Iijima H; Kawase K; Yamamoto T; Nakamura M
Clinical Ophthalmology 2009; 3: 183-188
25457 Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients
Ishikawa M; Yoshitomi T
Clinical Ophthalmology 2009; 3: 493-500
25447 24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
Ishikawa S; Nakamura Y; Sakai H; Henzan I; Sawaguchi S
Clinical Ophthalmology 2009; 3: 395-400
25464 Comparative studies of RNFL thickness measured by OCT with global index of visual fields in patients with ocular hypertension and early open angle glaucoma
Taliantzis S; Papaconstantinou D; Koutsandrea C; Moschos M; Apostolopoulos M; Georgopoulos G
Clinical Ophthalmology 2009; 3: 373-379
25476 Reproducibility of measurements and variability of the classification algorithm of Stratus OCT in normal, hypertensive, and glaucomatous patients
Anton A; Castany M; Pazos-Lopez M; Cuadrado R; Flores A; Castilla M
Clinical Ophthalmology 2009; 3: 139-145
25473 Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma
Papaconstantinou D; Georgalas I; Kalantzis G; Karmiris E; Koutsandrea C; Diagourtas A; Ladas I; Georgopoulos G
Clinical Ophthalmology 2009; 3: 251-257
25458 Association of microsatellite polymorphisms of the GPDS1 locus with normal tension glaucoma in the Japanese population
Nakamura K; Ota M; Meguro A; Nomura N; Kashiwagi K; Mabuchi F; Iijima H; Kawase K; Yamamoto T; Nakamura M
Clinical Ophthalmology 2009; 3: 307-312
25470 Bevacizumab (Avastin(registered trademark)) for the management of anterior chamber neovascularization and neovascular glaucoma
Brouzas D; Charakidas A; Moschos M; Koutsandrea C; Apostolopoulos M; Baltatzis S
Clinical Ophthalmology 2009; 3: 685-688
25475 Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
Galanopoulos A; Goldberg I
Clinical Ophthalmology 2009; 3: 117-122
25450 Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
Horsley M B; Kahook M Y
Clinical Ophthalmology 2009; 3: 291-295
25465 A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
Godfrey D A; Peplinski L S; Stewart J A; Stewart W C
Clinical Ophthalmology 2009; 3: 189-194
25472 Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: A meta-analysis
Eyawo O; Nachega J; Lefebvre P; Meyer D; Rachlis B; Lee C -W; Kelly S; Mills E
Clinical Ophthalmology 2009; 3: 447-456
25471 Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
Smid S D
Clinical Ophthalmology 2009; 3: 663-670
25468 Oral versus topical carbonic anhydrase inhibitors in ocular hypertension after scleral tunnel cataract surgery
Al-Barrag A; Al-Shaer M; Al-Matary N; Bamashmous M
Clinical Ophthalmology 2009; 3: 357-362
25463 Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
Teus M A; Miglior S; Laganovska G; Volksone L; Romanowska-Dixon B; Gos R; Hollo G
Clinical Ophthalmology 2009; 3: 629-636
25456 Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
Beckers H J M; Schouten J S A G; Webers C A B
Clinical Ophthalmology 2009; 3: 593-599
25474 Preliminary results following the use of a fixed combination of timolol-brimonidine in patients with ocular hypertension and primary open-angle glaucoma
Papaconstantinou D; Georgalas I; Kourtis N; Pitsas C; Karmiris E; Koutsandrea C; Ladas I; Georgopoulos G
Clinical Ophthalmology 2009; 3: 227-230
25446 Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
Ozkurt Y B; Sengor T; Evciman T; Haboglu M; Bas G; Aydin S
Clinical Ophthalmology 2009; 3: 337-339
25459 Trabeculectomy with intraoperative retrobulbar triamcinolone acetonide
Kahook M Y; Camejo L; Noecker R J
Clinical Ophthalmology 2009; 3: 29-31
